Data and Safety Monitoring Committee (DSMC)
The DSMC is intended to oversee all aspects of data auditing, verify data validity and integrity, and ensure the safety of participants in all cancer clinical trials, including institutionally sponsored, investigator authored trials, and those trials without external monitoring that are active at Stanford University Cancer Center. All cancer clinical trials require auditing commensurate with the degree of risk involved in the study subject participation, as well as the size and complexity of the study. The DSMC audits all investigator-initiated research, and reviews safety reports (grade 3 and above), and protocol deviations for all Stanford Cancer Center studies.
DSMC 2009 Meeting Dates
Monday |
January 26th |
(CC 2103) |
Monday |
February 23rd |
(CC 2103) |
Monday |
March 16th |
(CC 2103) |
Monday |
April 20th |
(CC 2103) |
Tuesday |
May 18th |
(CC 2103) |
Monday |
June 15th |
(CC 2103) |
Monday |
July 20th |
(CC 2103) |
Monday |
August 17th |
(CC 2103) |
Monday |
September 21st |
(CC 2103) |
Monday |
October 19th |
(CC 2103) |
Monday |
November 16th |
(CC 2103) |
Monday |
December 14th |
(CC 2103) |
The DSMC ensures the safety of participants in all cancer clinical trials by reviewing grade 3 and above adverse events and protocol deviations. It is also responsible for data auditing to verify protocol compliance, data validity and integrity, for institutionally sponsored, investigator authored trials.
DSMC Resources
Trial Administration